We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$300B
AUM Growth
-$49.2B
Cap. Flow
-$29.5B
Cap. Flow %
-9.85%
Top 10 Hldgs %
13.34%
Holding
11,668
New
1,182
Increased
3,623
Reduced
5,175
Closed
1,160

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 7.19%
3 Healthcare 6.35%
4 Consumer Discretionary 5.55%
5 Industrials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTRS
11301
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
-16,200
Closed -$127K
SCPS
11302
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
$0 ﹤0.01%
100
-4,740
-98% -$4.58K
GHACW
11303
DELISTED
Gaming & Hospitality Acquisition Corp. Warrants
GHACW
$0 ﹤0.01%
1,597
+600
+60% +$265
GTPBW
11304
DELISTED
Gores Technology Partners II, Inc. Warrant
GTPBW
-100
Closed
GSEV
11305
DELISTED
Gores Holdings VII, Inc. Class A Common Stock
GSEV
-2,662
Closed -$26K
SSAAW
11306
DELISTED
Science Strategic Acquisition Corp. Alpha Warrant
SSAAW
$0 ﹤0.01%
+388
New +$161
SHACW
11307
DELISTED
SCP & CO Healthcare Acquisition Company Warrant
SHACW
$0 ﹤0.01%
64
-1
-2%
VTIQW
11308
DELISTED
VectoIQ Acquisition Corp. II Warrant
VTIQW
-1,220
Closed -$1K
AFACU
11309
DELISTED
Arena Fortify Acquisition Corp. Unit
AFACU
$0 ﹤0.01%
+2
New +$20
ZWRKW
11310
DELISTED
Z-Work Acquisition Corp. Warrant
ZWRKW
$0 ﹤0.01%
+836
New +$317
LAAAW
11311
DELISTED
Lakeshore Acquisition I Corp. Warrant
LAAAW
$0 ﹤0.01%
143
-2
-1% -$1
AKUS
11312
DELISTED
Akouos Inc
AKUS
-2,559
Closed -$22K
SWET
11313
DELISTED
Athlon Acquisition Corp. Class A Common stock
SWET
-2,103
Closed -$21K
TSIBW
11314
DELISTED
Tishman Speyer Innovation Corp. II Warrant
TSIBW
-582
Closed
LMACW
11315
DELISTED
Liberty Media Acquisition Corporation Warrants
LMACW
-8,024
Closed -$14K
LMACU
11316
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
-1,174
Closed -$12K
WPCA.WS
11317
DELISTED
Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCA.WS
$0 ﹤0.01%
101
-801
-89% -$613
FRWAW
11318
DELISTED
PWP Forward Acquisition Corp. I Warrant
FRWAW
$0 ﹤0.01%
200
SECO
11319
DELISTED
Secoo Holding Limited ADR
SECO
-1,555
Closed -$7K
FLACW
11320
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
$0 ﹤0.01%
158
+33
+26% +$14
AUS
11321
DELISTED
Austerlitz Acquisition Corporation I
AUS
-1,351
Closed -$13K
CLR
11322
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-9,000
Closed -$403K
HUGS.WS
11323
DELISTED
USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
HUGS.WS
$0 ﹤0.01%
218
-104
-32% -$116
ZEN
11324
PUT
DELISTED
ZENDESK INC
ZEN
-50,000
Closed -$5.21M
KIIIW
11325
DELISTED
Kismet Acquisition Three Corp. Warrant
KIIIW
$0 ﹤0.01%
338

Similar funds

UBS Group's Q1 2022 Portfolio in Review

As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $29.5B in Q1 2022, closing 1,160 positions and reducing 5,175 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Shell worth $66.6M.

  • UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
  • UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
  • UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
  • UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
  • UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
  • UBS Group opened 1,182 new positions and closed 1,160 in Q1 2022.
  • UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.